昭衍新药公告董事、监事及高管减持计划;智翔金泰新药获得临床试验批准|医药早参

每日经济新闻
Yesterday

NO.1 汉邦科技收到《无效宣告请求审查决定书》  汉邦科技于近日收到了国家知识产权局出具的《无效宣告请求审查决定书》。国家知识产权局对无效宣告请求人汉邦科技提出的思拓凡瑞典有限公司(英文名“Cytiva”)拥有的“分离介质浆料罐”(专利号:200980125060.3)专利权之无效宣告请求进行了审查,审查结论为宣告该专利权全部无效。  点评:专利无效宣告程序是知识产权领域的常规法律救济途径。本次...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10